Leukemia Drug for Mesothelioma? Lab Tests Show It’s Possible
New data suggests that doctors might have good luck using a leukemia drug to treat pleural mesothelioma. The drug in…
-
-
Genetics | New Drugs | New Studies | Research | Treatments
Could This Protein Play a Role in Survival of Pleural Mesothelioma?
Research funded by the National Cancer Institute has identified a protein that might play a key role in survival of… -
Europe | Immunotherapy | International | New Drugs | Treatments | Updates
First Patient Dosed in New Trial for Relapsed Mesothelioma
Doctors in the UK have started treatment on the first patient in the trial of a new drug combination for… -
New Drug Combination for Mesothelioma Wins FDA Approval
The FDA has approved a new drug combination for mesothelioma. It is the first systemic treatment for mesothelioma to win… -
Could Anti-Malaria Drug Become New Pleural Mesothelioma Treatment?
A new report suggests an anti-malaria drug called quinacrine has potential as a new pleural mesothelioma treatment. Before chloroquine became… -
FDA Approval of Keytruda will Help Some Mesothelioma Patients
The FDA approval of Keytruda this month may help some patients in their battle against asbestos cancer. Keytruda is the… -
Chemotherapy | Europe | International | New Drugs | New Studies | Research | Treatments
Second-Line Mesothelioma Treatment with Ramucirumab
A combination of ramucirumab (CYRAMZA) and gemcitabine creates a promising second-line mesothelioma treatment. New research shows the combination nearly doubled… -
Promising Data on New Mesothelioma Pill Presented at National Conference
Doctors researching a new mesothelioma pill presented research on the drug at a national virtual conference in May. The ASCO… -
Could ONCOS-102 Be a New First-Line Mesothelioma Treatment?
A new first-line mesothelioma treatment has moved a step closer to becoming reality. New data show that the immunotherapy drug… -
Curcumin Treatment for Mesothelioma: Research is Encouraging
The research on curcumin treatment for mesothelioma looks promising, but more hard science is needed before doctors can incorporate it…
